Insider Selling: Astera Labs (NASDAQ:ALAB) General Counsel Sells 4,620 Shares of Stock

Astera Labs, Inc. (NASDAQ:ALAB) General Counsel Philip Mazzara sold 4,620 shares of the stock in a transaction on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $668,467.80. Following the completion of the sale, the general counsel directly owned 147,040 shares of the company’s stock, valued at approximately $21,275,217.60. This trade represents a 3.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Philip Mazzara also recently made the following trade(s):

• On Monday, November 17th, Philip Mazzara sold 4,620 shares of Astera Labs stock. The shares were sold at an average price of $144.69, for a total transaction of $668,467.80.
• On Wednesday, October 1st, Philip Mazzara sold 10,000 shares of Astera Labs stock. The stock was sold at an average price of $192.16, for a total transaction of $1,921,600.00.
• On Thursday, August 28th, Philip Mazzara sold 10,000 shares of Astera Labs stock. The shares were sold at an average price of $188.70, for a total value of $1,887,000.00.

Astera Labs Stock Performance

Shares of Astera Labs stock traded up $2.49 during trading hours on Wednesday, hitting $142.01. The company’s stock had a trading volume of 4,170,056 shares, compared to its average volume of 5,264,290. The company has a market cap of $23.99 billion, a PE ratio of 127.94, a PEG ratio of 2.64 and a beta of 1.37. The business has a 50 day moving average price of $190.50 and a two-hundred day moving average price of $145.33. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The company had revenue of $230.58 million for the quarter, compared to the consensus estimate of $206.42 million. During the same quarter last year, the company earned $0.23 EPS. The firm’s quarterly revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, research analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Institutional Trading of Astera Labs

Several hedge funds have recently made changes to their positions in ALAB. Coldstream Capital Management Inc. purchased a new position in Astera Labs in the third quarter worth about $297,000. Danske Bank A S bought a new stake in shares of Astera Labs in the 3rd quarter valued at approximately $668,000. Silvant Capital Management LLC purchased a new position in shares of Astera Labs in the 3rd quarter worth approximately $2,200,000. Advisory Services Network LLC increased its position in shares of Astera Labs by 33.1% during the 3rd quarter. Advisory Services Network LLC now owns 10,184 shares of the company’s stock valued at $1,994,000 after purchasing an additional 2,533 shares during the last quarter. Finally, Harvest Investment Services LLC bought a new position in shares of Astera Labs during the 3rd quarter valued at approximately $502,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently commented on ALAB shares. Roth Capital boosted their target price on shares of Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Astera Labs from $160.00 to $200.00 and gave the company a “buy” rating in a report on Tuesday, September 2nd. JPMorgan Chase & Co. lifted their target price on Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Astera Labs in a research report on Wednesday, October 8th. Finally, Stifel Nicolaus raised their price target on Astera Labs from $185.00 to $200.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and an average price target of $184.82.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.